Puma Biotechnology, Inc.PBYINASDAQ
Loading
Free Cash Flow Growth Under PressureDecelerating
Percentile Rank64
Studio
Year-over-Year Change

Year-over-year free cash flow growth rate

Percentile
P64
Within normal range
vs 2Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
PeriodValue
20257.38%
2024170.46%
2023162.95%
2022-210.54%
2021207.30%
2020-187.20%
2019189.32%
201888.92%
2017-49.63%
20164.30%